• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过高通量筛选试验发现、表征藤黄酸作为一种强效凋亡诱导剂及其构效关系。

Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay.

作者信息

Zhang Han-Zhong, Kasibhatla Shailaja, Wang Yan, Herich John, Guastella John, Tseng Ben, Drewe John, Cai Sui Xiong

机构信息

Maxim Pharmaceuticals, Inc., 6650 Nancy Ridge Drive, San Diego, CA 92121, USA.

出版信息

Bioorg Med Chem. 2004 Jan 15;12(2):309-17. doi: 10.1016/j.bmc.2003.11.013.

DOI:10.1016/j.bmc.2003.11.013
PMID:14723951
Abstract

Gambogic acid (2), a natural product isolated from the resin of Garcinia hurburyi tree, was discovered to be a potent apoptosis inducer using our cell- and caspase-based high-throughput screening assays. Gambogic acid was found to have an EC(50) of 0.78 microM in the caspase activation assay in T47D breast cancer cells. The apoptosis-inducing activity of gambogic acid was further characterized by a nuclear fragmentation assay and flow cytometry analysis in human breast tumor cells T47D. Gambogic acid was found to induce apoptosis independent of cell cycle, which is different from paclitaxel that arrests cells in the G2/M phase. To understand the structure-activity relationship (SAR) of gambogic acid, derivatives of 2 with modifications to different function groups were prepared. SAR studies of gambogic acid, as measured by the caspase activation assay, showed that the 9,10 carbon-carbon double bond of the alpha,beta-unsaturated ketone is important for biological activity, while the 6-hydroxy and 30-carboxy group can tolerate a variety of modifications. The importance of the 9,10 carbon-carbon double bond was confirmed by the traditional growth inhibition assay. The high potency of 2 as an inducer of apoptosis, its novel mechanism of action, easy isolation and abundant supply, as well as the fact that it is amenable to chemical modification, makes gambogic acid an attractive molecule for the development of anticancer agents.

摘要

藤黄酸(2)是从藤黄树树脂中分离得到的一种天然产物,通过我们基于细胞和半胱天冬酶的高通量筛选试验,发现它是一种有效的凋亡诱导剂。在T47D乳腺癌细胞的半胱天冬酶激活试验中,藤黄酸的EC(50)为0.78微摩尔。通过核碎裂试验和流式细胞术分析,在人乳腺肿瘤细胞T47D中进一步表征了藤黄酸的凋亡诱导活性。发现藤黄酸诱导凋亡与细胞周期无关,这与使细胞停滞在G2/M期的紫杉醇不同。为了了解藤黄酸的构效关系(SAR),制备了对不同官能团进行修饰的2的衍生物。通过半胱天冬酶激活试验测定的藤黄酸的SAR研究表明,α,β-不饱和酮的9,10碳-碳双键对生物活性很重要,而6-羟基和30-羧基可以耐受多种修饰。传统的生长抑制试验证实了9,10碳-碳双键的重要性。2作为凋亡诱导剂的高效性、其新颖的作用机制、易于分离和丰富的供应,以及它适合化学修饰这一事实,使得藤黄酸成为开发抗癌药物的一个有吸引力的分子。

相似文献

1
Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay.通过高通量筛选试验发现、表征藤黄酸作为一种强效凋亡诱导剂及其构效关系。
Bioorg Med Chem. 2004 Jan 15;12(2):309-17. doi: 10.1016/j.bmc.2003.11.013.
2
Studies on chemical modification and biology of a natural product, gambogic acid (II): Synthesis and bioevaluation of gambogellic acid and its derivatives from gambogic acid as antitumor agents.天然产物藤黄酸的化学修饰与生物学研究(II):藤黄酸及其衍生物的合成与生物评价作为抗肿瘤剂。
Eur J Med Chem. 2010 Sep;45(9):4343-53. doi: 10.1016/j.ejmech.2010.04.037. Epub 2010 May 13.
3
Discovery of a Highly Potent and Novel Gambogic Acid Derivative as an Anticancer Drug Candidate.发现一种高效新型藤黄酸衍生物作为抗癌药物候选物。
Anticancer Agents Med Chem. 2021;21(9):1110-1119. doi: 10.2174/1871520620666200408080040.
4
Studies on chemical structure modification and biology of a natural product, gambogic acid (I): Synthesis and biological evaluation of oxidized analogues of gambogic acid.天然产物藤黄酸的化学结构修饰及生物学研究(I):藤黄酸氧化类似物的合成及生物学评价
Eur J Med Chem. 2009 Jun;44(6):2611-20. doi: 10.1016/j.ejmech.2008.09.034. Epub 2008 Oct 7.
5
Studies on chemical modification and biology of a natural product, gambogic acid (III): determination of the essential pharmacophore for biological activity.天然产物藤黄酸(III)的化学修饰与生物学研究:生物活性必需药效团的确定。
Eur J Med Chem. 2011 Apr;46(4):1280-90. doi: 10.1016/j.ejmech.2011.01.051. Epub 2011 Feb 3.
6
Studies on chemical structure modification and structure-activity relationship of derivatives of gambogic acid at C(39).关于 C(39)位藤黄酸衍生物的化学结构修饰和构效关系的研究。
Chem Biodivers. 2012 Aug;9(8):1579-90. doi: 10.1002/cbdv.201100415.
7
Novel natural-product-like caged xanthones with improved druglike properties and in vivo antitumor potency.具有改善的类药物性质和体内抗肿瘤效力的新型天然产物样笼状呫吨酮。
Bioorg Med Chem Lett. 2015 Jun 15;25(12):2584-8. doi: 10.1016/j.bmcl.2015.04.031. Epub 2015 Apr 18.
8
Synthesis and evaluation of gambogic acid derivatives as antitumor agents. Part III.藤黄酸衍生物的合成与评价作为抗肿瘤剂。第三部分。
Chem Biodivers. 2013 Jan;10(1):73-85. doi: 10.1002/cbdv.201200126.
9
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group.利用基于细胞和半胱天冬酶的高通量筛选试验发现4-芳基-4H-色烯作为一系列新的凋亡诱导剂。1. 4-芳基基团的构效关系。
J Med Chem. 2004 Dec 2;47(25):6299-310. doi: 10.1021/jm049640t.
10
[Progress in research of the structural optimization of natural product-like Garcinia caged xanthones].[天然产物样藤黄属笼状呫吨酮结构优化的研究进展]
Yao Xue Xue Bao. 2014 Mar;49(3):293-302.

引用本文的文献

1
Design, Synthesis and Anti-cancer Evaluation of Nitrogen-containing Derivatives of 30-Carboxyl of Gambogic Acid.设计、合成并评价 30-羧基藤黄酸的含氮衍生物的抗癌活性。
Anticancer Agents Med Chem. 2024;24(6):454-463. doi: 10.2174/0118715206279725231208065031.
2
Caged Polyprenylated Xanthones in and the Biological Activities of Them.笼状多聚异戊烯基黄酮及其生物活性。
Drug Des Devel Ther. 2023 Dec 5;17:3625-3660. doi: 10.2147/DDDT.S426685. eCollection 2023.
3
-Trisubstituted α,β-Unsaturated Esters and Acid Fluorides through Stereocontrolled Catalytic Cross-Metathesis.
通过立体控制催化交叉复分解反应合成三取代的α,β-不饱和酯和酸氟化物。
J Am Chem Soc. 2023 Feb 15;145(6):3748-3762. doi: 10.1021/jacs.2c13245. Epub 2023 Jan 31.
4
Investigations into the antibacterial effects and potential mechanism of gambogic acid and neogambogic acid.藤黄酸和新藤黄酸的抗菌作用及潜在机制研究
Front Microbiol. 2022 Dec 12;13:1045291. doi: 10.3389/fmicb.2022.1045291. eCollection 2022.
5
A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma.综述:PI3K/AKT/mTOR信号通路及其调控的真核生物翻译起始因子可能是食管鳞状细胞癌的潜在治疗靶点。
Front Oncol. 2022 Apr 28;12:817916. doi: 10.3389/fonc.2022.817916. eCollection 2022.
6
Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs.藤黄酸及其衍生物作为抗肿瘤药物的研究进展。
Molecules. 2022 May 4;27(9):2937. doi: 10.3390/molecules27092937.
7
Localized disruption of redox homeostasis boosting ferroptosis of tumor by hydrogel delivery system.水凝胶递送系统局部破坏氧化还原稳态促进肿瘤铁死亡
Mater Today Bio. 2021 Nov 2;12:100154. doi: 10.1016/j.mtbio.2021.100154. eCollection 2021 Sep.
8
Gambogic Acid Inhibits Wnt/β-catenin Signaling and Induces ER Stress-Mediated Apoptosis in Human Cholangiocarcinoma.藤黄酸抑制 Wnt/β-连环蛋白信号通路并诱导人胆管癌细胞发生内质网应激相关凋亡。
Asian Pac J Cancer Prev. 2021 Jun 1;22(6):1913-1920. doi: 10.31557/APJCP.2021.22.6.1913.
9
Targeted Chinese Medicine Delivery by A New Family of Biodegradable Pseudo-Protein Nanoparticles for Treating Triple-Negative Breast Cancer: and Study.一种新型可生物降解伪蛋白纳米颗粒用于靶向递送中药治疗三阴性乳腺癌的研究
Front Oncol. 2021 Jan 20;10:600298. doi: 10.3389/fonc.2020.600298. eCollection 2020.
10
Gambogic Acid as a Candidate for Cancer Therapy: A Review.藤黄酸作为癌症治疗的候选药物:综述。
Int J Nanomedicine. 2020 Dec 22;15:10385-10399. doi: 10.2147/IJN.S277645. eCollection 2020.